Abstract
Anti-cancer medications constitute a critical part of lung cancer treatment. While absolute adherence to these medication plans is not expected, there is not enough real world data to analyse and measure adherence, complicating any efforts to improve it. CareAcross, a digital multilingual platform which provides personalized, evidence-based support to cancer patients investigated patient behaviors and attitudes towards cancer medication adherence.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have